Anti-IGFR1 antibody therapeutic combinations
US8017735B2 · kind B2 · utility
0Cited by
31References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2004 |
| Grant date | Sep 13, 2011 |
| Priority date | — |
| Expiry date | May 5, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides combinations including a binding composition, such as an anti-IGFR1 antibody, in association with a chemotherapeutic agent. Methods for using the combinations to treat medical conditions, such as cancer, are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.